FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313379868> ?p ?o ?g. }

• W4313379868 endingPage "116013" @default.
• W4313379868 startingPage "116013" @default.
• W4313379868 abstract "Cough variant asthma (CVA) is a chronic inflammatory disease characterized by cough as the main symptom. Suhuang antitussive capsule (Suhuang), one of traditional Chinese patent medicines, mainly treats CVA clinically. Previous studies have shown that Suhuang significantly improved CVA, post-infectious cough (PIC), sputum obstruction and airway remodeling. However, the effect of Suhuang on ovalbumin-induced (OVA-induced) metabolic abnormalities in CVA is unknown. This study aimed to identify potential metabolites associated with efficacy of Suhuang in the treatment of CVA, and determined how Suhuang regulates metabolites, and differential metabolites reduce inflammation and oxidative stress. Rats were given 1 mg OVA/100 mg aluminum hydroxide in the 1st and 7th days by intraperitoneal injection and challenged by atomizing inhalation of 1% OVA saline solution after two weeks to establish the CVA model. Rats were intragastrically (i.g.) administrated with Suhuang at 1.4 g/kg and β-hydroxybutyric acid (β-HB) were given with different concentrations (87.5 and 175 mg/kg/day) by intraperitoneal injection for 2 weeks. After 26 days, GC-MS-based metabolomic approach was applied to observe metabolic changes and search differential metabolites. The number of coughs, coughs latencies, enzyme-linked immunosorbent assay (ELISA), histological analysis and quantitative-polymerase chain reaction (Q-PCR) were used to investigate the effects of Suhuang. Then β-HB on CVA rats, NLRP3 inflammasome and GSK3β/AMPK/Nrf2 signalling pathway were detected by western blotting. The results showed that Suhuang treatment significantly enhanced the serum level of β-HB. Interestingly, exposure to exogenous β-HB was also protective against OVA-induced CVA. β-HB significantly reduced the number of coughs and lengthened coughs latencies, improved lung injury, reduced the secretion of various cytokines, and directly inhibited the NLRP3 inflammasome. In addition, β-HB increased the nuclear accumulation of Nrf2 by activating the GSK3β/AMPK signaling axis, and then inactivating the NF-κB signaling pathway, effectively protecting OVA-induced CVA from oxidative stress and inflammation. The results of this study shows that β-HB can reduce inflammation and oxidative stress, the increased production of β-HB in serum might be the crucial factor for Suhuang to exert its effect in the treatment of CVA." @default.
• W4313379868 created "2023-01-06" @default.
• W4313379868 creator A5002096737 @default.
• W4313379868 creator A5014682485 @default.
• W4313379868 creator A5015057605 @default.
• W4313379868 creator A5027792053 @default.
• W4313379868 creator A5031519477 @default.
• W4313379868 creator A5034619979 @default.
• W4313379868 creator A5037366883 @default.
• W4313379868 creator A5059256419 @default.
• W4313379868 creator A5063196569 @default.
• W4313379868 creator A5068564257 @default.
• W4313379868 date "2023-05-01" @default.
• W4313379868 modified "2023-10-16" @default.
• W4313379868 title "β-Hydroxybutyric acid upregulated by Suhuang antitussive capsule ameliorates cough variant asthma through GSK3β/AMPK-Nrf2 signal axis" @default.
• W4313379868 cites W1988537334 @default.
• W4313379868 cites W2081262717 @default.
• W4313379868 cites W2136503478 @default.
• W4313379868 cites W2155516660 @default.
• W4313379868 cites W2346141251 @default.
• W4313379868 cites W2519885630 @default.
• W4313379868 cites W2562858475 @default.
• W4313379868 cites W2592327439 @default.
• W4313379868 cites W2792880473 @default.
• W4313379868 cites W2810293347 @default.
• W4313379868 cites W2896236446 @default.
• W4313379868 cites W2900745529 @default.
• W4313379868 cites W2909181755 @default.
• W4313379868 cites W2910524075 @default.
• W4313379868 cites W2918568966 @default.
• W4313379868 cites W2938073209 @default.
• W4313379868 cites W2952520583 @default.
• W4313379868 cites W2958822943 @default.
• W4313379868 cites W2969579527 @default.
• W4313379868 cites W2982307597 @default.
• W4313379868 cites W2991041523 @default.
• W4313379868 cites W2991457324 @default.
• W4313379868 cites W2994663547 @default.
• W4313379868 cites W2996313928 @default.
• W4313379868 cites W3043293892 @default.
• W4313379868 cites W3081957004 @default.
• W4313379868 cites W3115092556 @default.
• W4313379868 cites W3116398810 @default.
• W4313379868 cites W3119232334 @default.
• W4313379868 cites W3136914534 @default.
• W4313379868 cites W3152941924 @default.
• W4313379868 cites W3157311678 @default.
• W4313379868 cites W3164251406 @default.
• W4313379868 cites W3165154899 @default.
• W4313379868 cites W3165836047 @default.
• W4313379868 cites W3176434375 @default.
• W4313379868 cites W3177554168 @default.
• W4313379868 cites W3200018585 @default.
• W4313379868 cites W4200013068 @default.
• W4313379868 cites W4283331511 @default.
• W4313379868 doi "https://doi.org/10.1016/j.jep.2022.116013" @default.
• W4313379868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36586526" @default.
• W4313379868 hasPublicationYear "2023" @default.
• W4313379868 type Work @default.
• W4313379868 citedByCount "1" @default.
• W4313379868 countsByYear W43133798682023 @default.
• W4313379868 crossrefType "journal-article" @default.
• W4313379868 hasAuthorship W4313379868A5002096737 @default.
• W4313379868 hasAuthorship W4313379868A5014682485 @default.
• W4313379868 hasAuthorship W4313379868A5015057605 @default.
• W4313379868 hasAuthorship W4313379868A5027792053 @default.
• W4313379868 hasAuthorship W4313379868A5031519477 @default.
• W4313379868 hasAuthorship W4313379868A5034619979 @default.
• W4313379868 hasAuthorship W4313379868A5037366883 @default.
• W4313379868 hasAuthorship W4313379868A5059256419 @default.
• W4313379868 hasAuthorship W4313379868A5063196569 @default.
• W4313379868 hasAuthorship W4313379868A5068564257 @default.
• W4313379868 hasConcept C104317684 @default.
• W4313379868 hasConcept C126322002 @default.
• W4313379868 hasConcept C127561419 @default.
• W4313379868 hasConcept C181199279 @default.
• W4313379868 hasConcept C185592680 @default.
• W4313379868 hasConcept C203014093 @default.
• W4313379868 hasConcept C2776042228 @default.
• W4313379868 hasConcept C2776151105 @default.
• W4313379868 hasConcept C2776719499 @default.
• W4313379868 hasConcept C2776914184 @default.
• W4313379868 hasConcept C2776946954 @default.
• W4313379868 hasConcept C2776954882 @default.
• W4313379868 hasConcept C2780124434 @default.
• W4313379868 hasConcept C2780159080 @default.
• W4313379868 hasConcept C42219234 @default.
• W4313379868 hasConcept C55493867 @default.
• W4313379868 hasConcept C71924100 @default.
• W4313379868 hasConcept C8891405 @default.
• W4313379868 hasConcept C97029542 @default.
• W4313379868 hasConcept C98274493 @default.
• W4313379868 hasConceptScore W4313379868C104317684 @default.
• W4313379868 hasConceptScore W4313379868C126322002 @default.
• W4313379868 hasConceptScore W4313379868C127561419 @default.
• W4313379868 hasConceptScore W4313379868C181199279 @default.
• W4313379868 hasConceptScore W4313379868C185592680 @default.
• W4313379868 hasConceptScore W4313379868C203014093 @default.

• next